Metropolitan Life Insurance Company (MetLife)’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,818
| Closed | -$19.3K | – | 1548 |
|
|
2024
Q1 | $19.3K | Hold |
1,818
| – | – | ﹤0.01% | 1880 |
|
|
2023
Q4 | $16.6K | Hold |
1,818
| – | – | ﹤0.01% | 1994 |
|
|
2023
Q3 | $18.9K | Buy |
1,818
+445
| +32% | +$4.62K | ﹤0.01% | 1929 |
|
|
2023
Q2 | $19.7K | Hold |
1,373
| – | – | ﹤0.01% | 1941 |
|
|
2023
Q1 | $9.8K | Sell |
1,373
-29
| -2% | -$207 | ﹤0.01% | 2165 |
|
|
2022
Q4 | $15.7K | Hold |
1,402
| – | – | ﹤0.01% | 2119 |
|
|
2022
Q3 | $15.5K | Hold |
1,402
| – | – | ﹤0.01% | 2141 |
|
|
2022
Q2 | $11.8K | Hold |
1,402
| – | – | ﹤0.01% | 2279 |
|
|
2022
Q1 | $19.1K | Sell |
1,402
-4,540
| -76% | -$61.8K | ﹤0.01% | 2120 |
|
|
2021
Q4 | $117K | Hold |
5,942
| – | – | ﹤0.01% | 2381 |
|
|
2021
Q3 | $191K | Hold |
5,942
| – | – | ﹤0.01% | 2112 |
|
|
2021
Q2 | $201K | Buy |
5,942
+2,355
| +66% | +$79.7K | ﹤0.01% | 2139 |
|
|
2021
Q1 | $135K | Hold |
3,587
| – | – | ﹤0.01% | 2277 |
|
|
2020
Q4 | $119K | Hold |
3,587
| – | – | ﹤0.01% | 2265 |
|
|
2020
Q3 | $132K | Hold |
3,587
| – | – | ﹤0.01% | 2057 |
|
|
2020
Q2 | $118K | Hold |
3,587
| – | – | ﹤0.01% | 2151 |
|
|
2020
Q1 | $92.6K | Buy |
+3,587
| New | +$92.6K | ﹤0.01% | 2074 |
|